Nagy C, Maitra M, Tanti A, Suderman M, Throux J-F, Davoli MA, Perlman K, Yerko V, Wang YC, Tripathy SJ, Pavlidis P, Mechawar N, Ragoussis J, Turecki G (2020) Single-nucleus transcriptomics of the prefrontal cortex in major depressive disorder implicates oligodendrocyte precursor cells and excitatory neurons
The thigh has slightly denser nerve distribution in some areas compared to the abdomen
The result in phase 2 clinical trials was 24.2% mean body weight reduction at 48 weeks with the 12mg dose, and the first phase 3 TRIUMPH-4 trial reported an average of 28.7% weight loss at 68 weeks
This makes it a preferred solvent for peptide reconstitution, solution preparation, and experimental consistency in controlled research environments
No Growth Hormone Effects The peptide contains only the 177-191 segment of growth hormone, which means it provides the metabolic benefits without the unwanted growth effects associated with full growth hormone therapy
published Phase I safety data in healthy volunteers were reported in conference proceedings, while completed Phase II efficacy results have not appeared in peer-reviewed literature